Most Read Articles
Elvira Manzano, 2 days ago
Monthly injections of the PCSK9* monoclonal antibody evolocumab effectively reduced plasma LDL-cholesterol (LDL-C), often referred to as the bad cholesterol, in teenagers with heterozygous familial hypercholesterolaemia (HeFH) already taking statins, with or without ezetimibe, the HAUSER-RCT has shown.
Jairia Dela Cruz, 2 days ago
For individuals with type 2 diabetes, losing weight is everything when it comes to improving the metabolic function, and it matters little whether this is achieved by dieting or undergoing bariatric surgery, according to a small study.
Pearl Toh, 21 Sep 2020
Early and sustained treatments with simplified regimen are the key to achieving good asthma control, said experts during a presentation at the ERS 2020 Congress.
3 days ago
In patients with type 2 diabetes (T2D), postprandial hyperglycaemia and hypertriglyceridemia worsens survival outlook, finds a new study.

Mood disorders tied to poor visuospatial memory performance

30 Nov 2019

Individuals with bipolar disorder and depression are likely to have lower visuospatial memory performance, which may partly be attributed to psychotropic medication use, a study has found.

The study used baseline data from the UK Biobank cohort and included 2,709 individuals with bipolar disorder and 102,931 matched controls, as well as 50,975 individuals with major depression and 105,284 matched controls.

Researchers evaluated reasoning, reaction time and memory, as well as the magnitude of the effect that was explained by potentially modifiable intermediate factors such as cardiometabolic disease and psychotropic medication.

Results for visuospatial memory performance revealed small between-group differences. Z-score differences were in the range of –0.23 to –0.17 (95 percent confidence interval [CI], –0.39 to –0.03) for the bipolar disorder group across different estimation methods, and were approximately –0.07 (95 percent CI, –0.10 to –0.03) for the major depression group.

Mediation analysis showed that one-quarter of the effect was explained by psychotropic medication in the bipolar disorder group (–0.05, 95 percent CI, –0.09 to –0.01), whereas no evidence was found via cardiometabolic disease.

The findings point to psychotropic medications as potential modifiable causes of cognitive impairment in patients with mood disorders, the researchers said.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Psychiatry - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Elvira Manzano, 2 days ago
Monthly injections of the PCSK9* monoclonal antibody evolocumab effectively reduced plasma LDL-cholesterol (LDL-C), often referred to as the bad cholesterol, in teenagers with heterozygous familial hypercholesterolaemia (HeFH) already taking statins, with or without ezetimibe, the HAUSER-RCT has shown.
Jairia Dela Cruz, 2 days ago
For individuals with type 2 diabetes, losing weight is everything when it comes to improving the metabolic function, and it matters little whether this is achieved by dieting or undergoing bariatric surgery, according to a small study.
Pearl Toh, 21 Sep 2020
Early and sustained treatments with simplified regimen are the key to achieving good asthma control, said experts during a presentation at the ERS 2020 Congress.
3 days ago
In patients with type 2 diabetes (T2D), postprandial hyperglycaemia and hypertriglyceridemia worsens survival outlook, finds a new study.